Screener
Monte Rosa Therapeutics, Inc. GLUE Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Monte Rosa Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Monte Rosa Therapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:09 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336711
| (in thousands) | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|
| Defined benefit plan liability | 85 | 957 |
| Right-of-use assets and operating lease liabilities | (874) | (427) |
| Deferred revenue | (13,177) | (106,910) |
| Net cash used in operating activities | $(81,483) | $(80,212) |
| Cash flows from investing activities: | ||
| Purchases of property and equipment | (6,591) | (3,282) |
| Purchases of marketable securities | (408,071) | (157,047) |
| Proceeds from maturities of marketable securities | 124,805 | 85,424 |
Item 1. Financial Statements
FAQ
- What is Monte Rosa Therapeutics, Inc.'s operating cash flow?
- Monte Rosa Therapeutics, Inc. (GLUE) reported operating cash flow of -$44.11M in Q2 2026.
- How has Monte Rosa Therapeutics, Inc.'s operating cash flow changed year-over-year?
- Monte Rosa Therapeutics, Inc.'s operating cash flow decreased by 27.1% year-over-year, from -$34.72M to -$44.11M.
- What is the long-term trend for Monte Rosa Therapeutics, Inc.'s operating cash flow?
- Over 3 years (2021 to 2025), Monte Rosa Therapeutics, Inc.'s operating cash flow has grown at a -27.3% compound annual growth rate (CAGR), from -$59.36M to -$22.8M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Monte Rosa Therapeutics, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude